SU can trigger insulin secretion in a glucose-dependent manner, lower blood glucose levels, and partially improve insulin deficiency in T2D by binding to the sulfonylurea receptor (SUR) of the ATP-sensitive potassium (KATP) channel and inducing channel closure [5,6]. Here, INS is linked to type 2 diabetes mellitus.